Beau Bosko Toskich/mayoclinic.org
May 2, 2025, 10:51
Beau Bosko Toskich: Combining Local Therapy and Immunotherapy in Intermediate Stage HCC
Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida, shared a post on X by HCC CONNECT, adding:
“What you should know about the intermediate stage HCC and combining local therapy plus immunotherapy. Was a real pleasure to work with my friend and colleague Ruth He and the awesome CORE2ED team.”
Quoting HCC CONNECT’s post:
“New micro learning alert! Explore the evolving role of immunotherapy in HCC with expert insights from medical oncologist Prof. Ruth He and interventional radiologist Prof. Beau Bosko Toskich. IO and IO combinations are transforming the treatment landscape for patients with advanced and intermediate HCC who aren’t candidates for local therapy.
Are you up to date on treatment strategies that combine locoregional and systemic therapies in intermediate HCC? Watch our short animated video now. Plus: get the 1-page flashcard + downloadable slide deck. Endorsed by Digestive Cancers Europe, Global Liver Institute and European Liver Patients’ Association. AstraZeneca has provided a sponsorship grant towards this independent programme.”
Proceed to the video attached to the post.
More posts featuring Beau Bosko Toskich.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 2, 2025, 10:31
May 2, 2025, 10:21
May 2, 2025, 10:19